In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
134 News Items found
Physician-scientist Omar Abdel-Wahab
In the Lab
Research Suggests How Boosting Neoantigens Can Make Immunotherapy More Effective

In mice, drugs that change the way proteins are assembled appear to make checkpoint inhibitor drugs work better.
Hands on keyboard
New Tool to Predict Breast Cancer Metastasis

Memorial Sloan Kettering Cancer Center researchers have identified a feature in the DNA of breast cancer cells that might indicate the likelihood a woman's disease will become life threatening.
Sammy gets ready to swing a bat
MSK Earns Top Distinction for Pediatric Cancer Care From American College of Surgeons

Thanks to MSK’s expertise in treating young people with cancer, 16-year-old high school athlete Sammy is back to doing what he loves.
Craig Melvin
Why Colorectal Cancer Screening Is Crucial for Younger Adults and Black People

NBC News anchor Craig Melvin led MSK experts in a discussion about racial and age trends in colorectal cancer and when people should start screening for the disease.
DNA winding around histones
In the Lab
Research Clarifies How IDH Mutations Cause Cancer

The MSK team’s goal was to get at the underlying defects in cells that these mutations cause.
Luis A. Diaz, MD
Taking Giant Leaps: Luis Alberto Diaz, Jr., MD, of Memorial Sloan Kettering Cancer Center Inducted into Giants of Cancer Care® Class of 2022

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce Luis Alberto Diaz, Jr., MD, Head of the Division of Solid Tumor Oncology; Grayer Family Chair at MSK, has been elected to the 10th class of Giants of Cancer Care® for his contributions in translational science.
SKI immunologist Ming Li
SKI Scientists Identify Potential New ‘Soldier’ for Cancer Immunotherapy

The new cells, which the scientists have dubbed killer innate-like T cells, differ in several notable ways from the conventional target of many immunotherapies.
rod-shaped bacteria
Feature
Microorganisms in the Gut Can Affect Cancer Outcomes

Discover how microbiome research is revealing the role that bacteria play in cancer treatment.
Five MSK researcher headshots
ASCO 2021 Research Roundup: Focus on Immunotherapy

Read about the latest findings in immunotherapy from the 2021 annual meeting of the American Society of Clinical Oncology (ASCO).
Luis Portiansky
In the Clinic
How a Combination Therapy Developed at MSK Benefits People With a Rare Gastrointestinal Cancer

MSK researchers recently reported results of a phase 2 trial for GIST, a rare form of gastrointestinal cancer. The trial was based on years of lab work conducted by physician-scientist Ping Chi.